Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Price:
109.29 USD
-0.92%
Updated:
May 3, 2024
Jazz Pharmaceuticals PLC
Cash from Financing Activities
|
Jazz Pharmaceuticals PLC
Cash from Financing Activities Peer Comparison
Comparables:
PRGO
AVDL
G
GHRS
COPN
OVB
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
Cash from Financing Activities
-$305.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
9%
|
CAGR 10-Years
-29%
|
|
|
Perrigo Company PLC
NYSE:PRGO
|
Cash from Financing Activities
-$187.2m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
Cash from Financing Activities
$135.3m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
4%
|
CAGR 10-Years
22%
|
|
G
|
GH Research PLC
NASDAQ:GHRS
|
Cash from Financing Activities
-$204k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
Cash from Financing Activities
-€209.3m
|
CAGR 3-Years
-160%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Ovoca Bio PLC
LSE:OVB
|
Cash from Financing Activities
€888k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-9%
|
See Also
What is Jazz Pharmaceuticals PLC's Cash from Financing Activities?
Cash from Financing Activities
-305.3m
USD
-305.3m
USD
Based on the financial report for Dec 31, 2023, Jazz Pharmaceuticals PLC's Cash from Financing Activities amounts to -305.3m USD.
What is Jazz Pharmaceuticals PLC's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-29%
-29%
Over the last year, the Cash from Financing Activities growth was 42%.
You don't have any saved screeners yet
